antiviral agents / adverse effects

Explore academic connections and research related to this keyword

272
Views
13
Total Connections

Related Articles & Bibliographies

1
[COVID-19: a cardiological point-of-view]
Weckbach LT;Kellnar A;Stremmel C;Stark K;Kääb S;;
2020 deutsche medizinische wochenschrift (1946) 250 views
2
Telaprevir for previously untreated chronic hepatitis C virus infection
Jacobson IM;McHutchison JG;Dusheiko G;Di Bisceglie AM;Reddy KR;Bzowej NH;Marcellin P;Muir AJ;Ferenci...
2011 The New England journal of medicine 524 views
3
Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment
Reiff-Eldridge R;Heffner CR;Ephross SA;Tennis PS;White AD;Andrews EB;;
2000 american journal of obstetrics and gynecology 320 views
4
Boceprevir for untreated chronic HCV genotype 1 infection
Poordad F;McCone J;Bacon BR;Bruno S;Manns MP;Sulkowski MS;Jacobson IM;Reddy KR;Goodman ZD;Boparai N;...
2011 The New England journal of medicine 389 views
5
6
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study
Vu D;Peck AJ;Nichols WG;Varley C;Englund JA;Corey L;Boeckh M;;
2007 Clinical infectious diseases : an official publica... 305 views
7
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Kwo PY;Poordad F;Asatryan A;Wang S;Wyles DL;Hassanein T;Felizarta F;Sulkowski MS;Gane E;Maliakkal B;...
2017 journal of hepatology 361 views
8
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Dore GJ;Altice F;Litwin AH;Dalgard O;Gane EJ;Shibolet O;Luetkemeyer A;Nahass R;Peng CY;Conway B;Greb...
2016 annals of internal medicine 356 views
9
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Jacobson IM;Lawitz E;Gane EJ;Willems BE;Ruane PJ;Nahass RG;Borgia SM;Shafran SD;Workowski KA;Pearlma...
2017 gastroenterology 265 views
10
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Asselah T;Kowdley KV;Zadeikis N;Wang S;Hassanein T;Horsmans Y;Colombo M;Calinas F;Aguilar H;de Ledin...
2018 clinical gastroenterology and hepatology : the off... 299 views
11
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Foster GR;Afdhal N;Roberts SK;Bräu N;Gane EJ;Pianko S;Lawitz E;Thompson A;Shiffman ML;Cooper C;Towne...
2015 The New England journal of medicine 308 views
12
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
Liu CJ;Chuang WL;Lee CM;Yu ML;Lu SN;Wu SS;Liao LY;Chen CL;Kuo HT;Chao YC;Tung SY;Yang SS;Kao JH;Liu...
2009 gastroenterology 255 views
13
Sofosbuvir for previously untreated chronic hepatitis C infection
Lawitz E;Mangia A;Wyles D;Rodriguez-Torres M;Hassanein T;Gordon SC;Schultz M;Davis MN;Kayali Z;Reddy...
2013 The New England journal of medicine 326 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.